Stryker (NYSE: SYK), a global leader in medical technologies, announced today a definitive agreement to acquire all of the issued and outstanding shares of common stock of Inari Medical ...

Argus analyst David Toung raised the firm’s price target on Stryker (SYK) to $450 from $410 and keeps a Buy rating on the shares. Argus expects ...

Stryker, one of the world’s largest medtech companies, announced on January 28 that it would be selling its Spinal Implants business to ...

4. Zimmer Biomet has entered into a definitive agreement to purchase Paragon 28, a medical device company focused exclusively on foot-and-ankle orthopedics.

After two consecutive years of 20%-plus gains, the S&P 500 kicked off 2025 with a solid January performance. Investors are hoping the S&P 500 can continue to grind higher and maintain its ...

Inari Medical, Inc. NARI is well-poised for growth on the back of a huge market opportunity for its products and its commitment to understanding the venous system. However, the company’s dependency on ...

Now that the year is underway and a new presidential administration is in place in Washington, let’s consider the environment ...

Stryker Corp (NYSE:SYK) successfully completed seven acquisitions in 2024, contributing to its strong financial performance. The company announced a strategic acquisition of Inari, expanding its ...

Hospital has added a Stryker Mako robotic system for total knee, partial knee and total hip replacements. Robotic surgery allows for better analytics, outcomes and faster recovery for total knee, ...